Key result
Controlled blood pressure reduction with antihypertensive therapy successfully treated hypertension-induced thrombotic microangiopathy, improving platelet counts without requiring plasma exchange.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Hypertension-induced thrombotic microangiopathy can be effectively managed with controlled blood pressure reduction using antihypertensives, avoiding the need for invasive plasma exchange.
Hypertension causing thrombotic microangiopathy (TMA) is one of the several etiologies of TMA, which causes endothelial damage and thrombosis of microvasculature, leading to hemolytic anemia, thrombocytopenia, and ischemic organ damage. Renal microvasculature involvement leading to renal dysfunction is most frequently seen in TMA but the degree of dysfunction varies with etiology. If left untreated, TMA carries a risk of high mortality, so it is extremely important for early identification of the cause of TMA. Plasma exchange is a commonly used treatment modality for TMA; however, it is not always necessary. Hypertension-induced TMA can be safely treated with antihypertensives, without the need for invasive plasma exchange. We report a 37-year-old African American hypertensive lady presenting with hypertensive emergency and TMA with rapidly progressing renal dysfunction. The patient had improvement in her platelet count after her blood pressure was reduced in a controlled manner.
No takes yet. Share an insight, caveat, or question.
Bandaru et al. (2022) conducted a case report in Thrombotic microangiopathy secondary to hypertensive emergency (n=1). Antihypertensive therapy was evaluated on Platelet count and lactate dehydrogenase (LDH) levels. Controlled blood pressure reduction with antihypertensive therapy successfully treated hypertension-induced thrombotic microangiopathy, improving platelet counts without requiring plasma exchange.
Synapse has enriched 10 related papers. Consider them for comparative context: